HUNTSMAN RONALD KIRK (Chairman & CEO) purchased 19.3% of their position (14K shares) of VIVOS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $7.4K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/20/2023ACC: 0001493152-23-021910
DirectorOfficer10% Owner· Chairman & CEO
Since Dec 2020
+14K
Net shares
Net buyer
$7.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
14K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14K
Price / share
$0.53
Trade value
$7.42K
% of position
19.3%
6/20/2023
72.52K→86.52K
Total
Net shares
+14K
Net value
$7.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/20/2023 | P · Purchase | +14K | $0.53 | $7.42K | 19.3% | 72.52K | 86.52K |
| Total | +14K | $7.42K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.74M
Total
1.74M indirect1.74M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.74M | Indirect |
| Total | 1.74M | 1.74M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported